{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:35:53Z","timestamp":1777894553033,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.mycmed.2017.11.004","type":"journal-article","created":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T12:00:18Z","timestamp":1511956818000},"page":"374-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Luliconazole, a new antifungal against Candida species isolated from different sources"],"prefix":"10.1016","volume":"28","author":[{"given":"S.","family":"Taghipour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Kiasat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Shafiei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Halvaeezadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3119-8342","authenticated-orcid":false,"given":"A.","family":"Rezaei-Matehkolaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5347-2082","authenticated-orcid":false,"given":"A.","family":"Zarei Mahmoudabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2017.11.004_bib0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/myc.12168","article-title":"A review of a new antifungal agent for the topical treatment of onychomycosis","volume":"57","author":"Scher","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-280X.1999.00243.x","article-title":"Inhibition of sterol 14 alpha-demethylation of Candida albicans with nnd-502, a novel optically active imidazole antimycotic agent","volume":"37","author":"Niwano","year":"1999","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0015","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1080\/13693780802541518","article-title":"In vitro antifungal activities of luliconazole, a new topical imidazole","volume":"47","author":"Koga","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0020","first-page":"20","article-title":"A randomized, double-blind, vehicle-controlled trial of luliconazole cream 1% in the treatment of interdigital tinea pedis","volume":"7","author":"Draelos","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0924-8579(02)00362-X","article-title":"In vitro activity of novel imidazole antifungal agent nnd-502 against malassezia species","volume":"21","author":"Uchida","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0030","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s10156-004-0327-1","article-title":"In vitro antifungal activity of luliconazole (nnd-502), a novel imidazole antifungal agent","volume":"10","author":"Uchida","year":"2004","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/CE.S49629","article-title":"Luliconazole for the treatment of fungal infections: an evidence-based review","volume":"9","author":"Khanna","year":"2014","journal-title":"Core evidence"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1439-0507.2006.01305.x","article-title":"Dose-finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis \u2013\u00a0comparison between three groups (1%, 0.5%, 0.1%) by a multicenter randomised double-blind study","volume":"50","author":"Watanabe","year":"2007","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0045","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/AAC.02370-12","article-title":"Safety and tolerability of luliconazole solution 10-percent in patients with moderate to severe distal subungual onychomycosis","volume":"57","author":"Jones","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3314\/jjmm.50.207","article-title":"Guidelines for diagnosis and treatment of mucocutaneous candidiasis","volume":"50","author":"Katoh","year":"2009","journal-title":"Nihon Ishinkin Gakkai Zasshi"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0055","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1128\/AAC.05255-11","article-title":"Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis","volume":"56","author":"Koga","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3314\/jjmm.50.9","article-title":"Fungicidal activity of liranaftate against dermatophytes","volume":"50","author":"Oku","year":"2009","journal-title":"Nihon Ishinkin Gakkai Zasshi"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0065","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/AAC.48.5.1773-1777.2004","article-title":"Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis","volume":"48","author":"Bennett","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0070","doi-asserted-by":"crossref","first-page":"698736","DOI":"10.1155\/2013\/698736","article-title":"Clinical characteristics of Turkish women with Candida krusei vaginitis and antifungal susceptibility of the C.\u00a0Krusei isolates","volume":"2013","author":"Guzel","year":"2013","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0075","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1128\/AAC.01193-16","article-title":"Potent activities of novel imidazoles (lanoconazole and luliconazole) against a collection of azole resistant and susceptible aspergillus fumigatus strains","volume":"60","author":"Abastabar","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0080","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.mycmed.2017.04.011","article-title":"Luliconazole, an alternative antifungal agent against aspergillus terreus","volume":"27","author":"Zargaran","year":"2017","journal-title":"J Mycol Med"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0085","series-title":"J.H. Rex, B. D. Alexander, D. Andes, B. Arthington-Skaggs, S. D. Brown, V. Chaturvedi, et al. Refrence method for broth dilution abtifungal suceptibility testing of yeasts","first-page":"28","year":"2008"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0090","article-title":"Resazurin-based 96-well plate microdilution method for the determination of minimum inhibitory concentration of biosurfactants","author":"Mohamed","year":"2016","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0095","doi-asserted-by":"crossref","first-page":"e41446","DOI":"10.5812\/jjm.41446","article-title":"The Frequency, antifungal susceptibility and enzymatic profiles of Candida species isolated from neutropenic patients","volume":"9","author":"Gharaghani","year":"2016","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0100","first-page":"410","article-title":"Isolation, molecular identification and antifungal susceptibility profiles of vaginal isolates of Candida species","volume":"8","author":"Rezaei-Matehkolaei","year":"2016","journal-title":"Iran J Microbiol"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0105","doi-asserted-by":"crossref","first-page":"e17105","DOI":"10.5812\/jjm.17105","article-title":"Biofilm formation and susceptibility to amphotericin B and fluconazole in Candida albicans","volume":"7","author":"Zarei Mahmoudabadi","year":"2014","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0110","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1128\/AAC.02706-13","article-title":"Luliconazole demonstrates potent in vitro activity against dermatophytes recovered from patients with onychomycosis","volume":"58","author":"Wiederhold","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0115","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/mmy\/myw016","article-title":"In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates","volume":"54","author":"Baghi","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11046-016-0045-0","article-title":"New antifungal agents and new formulations against dermatophytes","volume":"182","author":"Gupta","year":"2017","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0125","first-page":"32","article-title":"A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged\u226512 years with tinea cruris","volume":"13","author":"Jones","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0130","first-page":"838","article-title":"Efficacy and safety of once-daily luliconazole 1% cream in patients\u226512 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind, vehicle-controlled study","volume":"13","author":"Jarratt","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4103\/2229-5178.185471","article-title":"Comparative assessment of the efficacy of topical ketoconazole and topical luliconazole in cases of pityriasis versicolor at a tertiary care hospital in Eastern India: a prospective, open, randomized controlled trial","volume":"7","author":"Sarkar","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0140","doi-asserted-by":"crossref","first-page":"J141","DOI":"10.3314\/mmj.16-00020","article-title":"Comparison of characteristics of two topical therapeutic agents for onychomycosis","volume":"57","author":"Shimamura","year":"2016","journal-title":"Med Mycol J"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0924-8579(99)00076-X","article-title":"Efficacy of nnd-502, a novel imidazole antimycotic agent, in experimental models of Candida albicans and Aspergillus fumigatus infections","volume":"12","author":"Niwano","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2017.11.004_bib0150","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4103\/0378-6323.156194","article-title":"Diaper dermatitis with psoriasiform id eruptions","volume":"81","author":"Balasubramanian","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523317301117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523317301117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:19:04Z","timestamp":1761110344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523317301117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1156523317301117"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2017.11.004","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Luliconazole, a new antifungal against Candida species isolated from different sources","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}